메뉴 건너뛰기




Volumn 2, Issue 1, 2005, Pages 4-5

What is the role of radiotherapy in bladder-preserving cancer therapy?

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; GEMCITABINE; TAXANE DERIVATIVE;

EID: 20444506096     PISSN: 17434254     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncponc0052     Document Type: Review
Times cited : (1)

References (11)
  • 1
    • 84944657811 scopus 로고
    • Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery
    • Shipley WU et al. (1987) Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA 285: 931-935
    • (1987) JAMA , vol.285 , pp. 931-935
    • Shipley, W.U.1
  • 2
    • 0027452436 scopus 로고
    • Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: A prospective study
    • Housset M et al. (1993) Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J Clin Oncol 11: 2150-2157
    • (1993) J. Clin. Oncol. , vol.11 , pp. 2150-2157
    • Housset, M.1
  • 3
    • 0003359974 scopus 로고    scopus 로고
    • Concomitant fluorouracil (5-FU)-cisplatin (CDDP) and bifractionated split course radiation therapy (BSCRT) for invasive bladder cancer
    • [abstract]
    • Housset M et al. (1997) Concomitant fluorouracil (5-FU)-cisplatin (CDDP) and bifractionated split course radiation therapy (BSCRT) for invasive bladder cancer [abstract]. Proc Am Soc Clin Oncol 16: a319
    • (1997) Proc. Am. Soc. Clin. Oncol. , vol.16
    • Housset, M.1
  • 4
    • 0025085522 scopus 로고
    • Radiotherapy with and without cisplatin in bladder cancer
    • Sauer R et al. (1990) Radiotherapy with and without cisplatin in bladder cancer. Int J Radiat Oncol Biol Phys 19: 687-691
    • (1990) Int. J. Radiat. Oncol. Biol. Phys. , vol.19 , pp. 687-691
    • Sauer, R.1
  • 5
    • 4344633285 scopus 로고    scopus 로고
    • Combined-modality therapy with gemcitabine and radiotherapy as a bladder preservation strategy: Results of a phase I trial
    • Kent E et al. (2004) Combined-modality therapy with gemcitabine and radiotherapy as a bladder preservation strategy: results of a phase I trial. J Clin Oncol 22: 2540-2545
    • (2004) J. Clin. Oncol. , vol.22 , pp. 2540-2545
    • Kent, E.1
  • 6
    • 0033754310 scopus 로고    scopus 로고
    • Radiation therapy and concomitant paclitaxel/carboplatin chemotherapy for muscle invasive transitional cell carcinoma of the bladder: A well-tolerated combination
    • Nichols RC Jr et al. (2000) Radiation therapy and concomitant paclitaxel/carboplatin chemotherapy for muscle invasive transitional cell carcinoma of the bladder: a well-tolerated combination. Int J Cancer 90: 281-286
    • (2000) Int. J. Cancer , vol.90 , pp. 281-286
    • Nichols Jr., R.C.1
  • 7
    • 0036214513 scopus 로고    scopus 로고
    • Distressful symptoms after radical radiotherapy for urinary bladder cancer
    • Henningsohn L et al. (2002) Distressful symptoms after radical radiotherapy for urinary bladder cancer. Radiother Oncol 62: 215-225
    • (2002) Radiother. Oncol. , vol.62 , pp. 215-225
    • Henningsohn, L.1
  • 8
    • 0141919743 scopus 로고    scopus 로고
    • Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: Results of a urodynamic and quality of life study on long-term survivors
    • Zietman AL et al. (2003) Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors. J Urol 170: 1772-1776
    • (2003) J. Urol. , vol.170 , pp. 1772-1776
    • Zietman, A.L.1
  • 9
    • 0034874086 scopus 로고    scopus 로고
    • Selective bladder conservation using transurethral resection, chemotherapy, and radiation: Management and consequences of Ta, T1, and Tis recurrence within the retained bladder
    • Zietman AL et al. (2001) Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder. Urology 58: 380-385
    • (2001) Urology , vol.58 , pp. 380-385
    • Zietman, A.L.1
  • 10
    • 0037099683 scopus 로고    scopus 로고
    • Combined-modality treatment and selective organ preservation in invasive bladder cancer: Long-term results
    • Rodel C et al. (2002) Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 20: 3061-3071
    • (2002) J. Clin. Oncol. , vol.20 , pp. 3061-3071
    • Rodel, C.1
  • 11
    • 0035254218 scopus 로고    scopus 로고
    • Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients
    • Stein JP et al. (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19: 666-675
    • (2001) J. Clin. Oncol. , vol.19 , pp. 666-675
    • Stein, J.P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.